Drj Impex Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 1.55 Cr
as on 17-12-2024
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.02 Cr
as on 17-12-2024
- Revenue 56.54%
(FY 2022)
- Profit 56.37%
(FY 2022)
- Ebitda 58.06%
(FY 2022)
- Net Worth 3.16%
(FY 2022)
- Total Assets -9.19%
(FY 2022)
About Drj Impex
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.55 Cr.
The company currently has active open charges totaling ₹19.02 Cr.
Alok Jain, Jinendra Jain, and Sourabh Jain serve as directors at the Company.
- CIN/LLPIN
U52100UP2015PTC069577
- Company No.
069577
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Etah, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Drj Impex?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Jain  | Director | 01-Aug-2020 | Current |
| Jinendra Jain | Director | 16-Mar-2015 | Current |
| Sourabh Jain | Director | 18-Sep-2020 | Current |
Financial Performance of Drj Impex.
Drj Impex Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 56.54% increase. The company also saw a substantial improvement in profitability, with a 56.37% increase in profit. The company's net worth moved up by a moderate rise of 3.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Drj Impex?
In 2021, Drj Impex had a promoter holding of 58.95% and a public holding of 41.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Dev Rishi Jain & Sons Private LimitedActive 4 years 1 month
Alok Jain and Jinendra Jain are mutual person
- Jinendra Prabha Drug House Private LimitedActive 18 years 5 months
Jinendra Jain and Sourabh Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 31 Dec 2018 | ₹10.85 Cr | Open |
Canara Bank Creation Date: 15 Mar 2016 | ₹1.25 Cr | Open |
Canara Bank Creation Date: 15 Mar 2016 | ₹6.92 Cr | Open |
How Many Employees Work at Drj Impex?
Unlock and access historical data on people associated with Drj Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Drj Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Drj Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
